Tamura Noriko
Seishin Shinkeigaku Zasshi. 2017;119(3):151-157.
In Japan, Clinical Practice Guidelines are defined as a document that presents appropriate recommendations to assist patients and practitioners in making decisions regarding clinical practice of marked importance, based on the body of evidence evaluated and integrated by systematic reviews and the balance between benefits and harm outlined by the Medical Information Network Distribution Services (Minds). Their successful implementation should improve the quality of care by decreasing inappropriate variation and expediting the application of effective advances to everyday practice. The process of developing CPGs includes dissemination, implementation, and assessment after publication. Some of the countries or guideline developers conducted research on factors of facilitators and barriers influencing the imple- mentation of CPGs. In Japanese mental health, little is known about the influence of CPGs. To gain an understanding of the current status of CPGs for mental health, we collected all published CPGs using the following databases: Minds website, Toho University and ICHUSHI Clinical Practice Guidelines Database, and J-GLOBAL. As a result, we found 1,117 articles. Because of the overlap among the 3 databases, trans- lated versions of foreign CPGs, commentaries, and review articles, 78 CPGs were extracted. We categorized the 78 CPGs into the following types : disease, writers, publication year, method of development, publication type, and revised or not. Through this survey, we found that there are many CPGs, they are difficult to identify, and their implementation and dissemination rates are unclear. CPGs are one type of medical information, and their use causes some challenges. When we develop CPGs, we have to per- form a systematic review of the evidence. It is known that there is a gap between evidence and practice in healthcare research. Also, multimorbidity is now very common. CPGs are gen- erally developed for a single disease, and so the application of CPGs is difficult when a patient has more than one disease. Although CPGs for mental health are being developed in Japan, there have been few studies on the influence, barriers, and facilitators of dissemination and implementation. Further research is needed on how to utiliz medical information effectively in order to improve the quality of health care.
在日本,临床实践指南被定义为一份文件,它基于通过系统评价评估和整合的证据以及医学信息网络分发服务(Minds)概述的利弊平衡,提出适当的建议,以帮助患者和从业者就具有显著重要性的临床实践做出决策。其成功实施应通过减少不适当的差异并加快将有效的进展应用于日常实践来提高医疗质量。制定临床实践指南的过程包括发布后的传播、实施和评估。一些国家或指南制定者对影响临床实践指南实施的促进因素和障碍进行了研究。在日本的心理健康领域,关于临床实践指南的影响知之甚少。为了解心理健康临床实践指南的现状,我们使用以下数据库收集了所有已发布的临床实践指南:Minds网站、东京大学和医中志临床实践指南数据库以及日本全球信息集成系统(J-GLOBAL)。结果,我们找到了1117篇文章。由于这3个数据库之间存在重叠、外国临床实践指南的翻译版本、评论和综述文章,共提取出78份临床实践指南。我们将这78份临床实践指南分为以下类型:疾病、作者、出版年份、制定方法、出版类型以及是否修订。通过这项调查,我们发现临床实践指南数量众多,难以识别,其实施和传播率也不明确。临床实践指南是一种医学信息类型,其使用带来了一些挑战。在制定临床实践指南时,我们必须对证据进行系统评价。众所周知,医疗保健研究中证据与实践之间存在差距。此外,多重疾病现在非常普遍。临床实践指南通常是针对单一疾病制定的,因此当患者患有多种疾病时,临床实践指南的应用就很困难。尽管日本正在制定心理健康临床实践指南,但关于传播和实施的影响、障碍和促进因素的研究很少。为了提高医疗保健质量,需要进一步研究如何有效利用医学信息。